Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,724 | -27,816 | -22,869 | -13,504 | -6,585 |
| Depreciation Amortization | 163 | 936 | 698 | 484 | 250 |
| Accounts receivable | 1,090 | 186 | 781 | 484 | 1,325 |
| Other Working Capital | 998 | 1,539 | 2,196 | 602 | 1,056 |
| Other Operating Activity | 190 | 1,702 | 1,620 | 1,186 | -575 |
| Operating Cash Flow | $-8,283 | $-23,453 | $-17,574 | $-10,748 | $-4,529 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -290 | -2,560 | -1,819 | -1,227 | -623 |
| Common Stock Issued | N/A | 62,151 | 22,939 | 22,939 | 22,938 |
| Other Financing Activity | 0 | -4,895 | -1,859 | -1,859 | -1,859 |
| Financing Cash Flow | $-290 | $54,696 | $19,261 | $19,853 | $20,456 |
| Exchange Rate Effect | 94 | -2,544 | -777 | -1,239 | -960 |
| Beginning Cash Position | 54,912 | 26,213 | 26,213 | 26,213 | 26,213 |
| End Cash Position | 46,433 | 54,912 | 27,123 | 34,079 | 41,180 |
| Net Cash Flow | $-8,479 | $28,699 | $910 | $7,866 | $14,967 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,283 | -23,453 | -17,574 | -10,748 | -4,529 |
| Free Cash Flow | -8,283 | -23,453 | -17,574 | -10,748 | -4,529 |